Comparison of Flutiform

Comparison of Flutiform and Foster according to the improvement of quality-of-life through asthma control

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003540

Enrollment

Registered

2019-02-20

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1) Prof. Sang Min Lee and Prof. Sung Yoon Kang who are in charge of randomization and drug handling randomly assigned subjects into Foster group® or Flutiform® group through “Microsoft EXCEL” p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age: 19 years or older 2. Typical symptom of asthma: dyspnea and wheezing which is aggravated at night and dawn, or by upper respiratory infection, exercise, climate change, air pollution, allergen exposure, stimulatory odor. 3. Reversible airway obstruction (FEV1 increase by 12% and 200ml after salbutamol inhalation or other asthma treatment) or airway hyperresponsiveness (PC20 16mg/mL or less in methacholine challenge test) 4. The use of inhaled coticosteroid and long-acting beta2 agonist is recommended according to the gulideline of Global Initiative of Asthma (GINA) (Step3) 5. Subjects who can use pressurized metered dose inhaler (pMDI).

Exclusion criteria

Exclusion criteria: 1. Malignancy or other severe diseases which can influence on this study 2. Patients who previously used Flutiform® or Foster®. 3. Pregnancy or lactation (for female subjects) 4. Flutiform® and Foster® are not appropriate to use for other reason 5. Subjects who do not want or reject to participate in this study

Design outcomes

Primary

Measure	Time frame
Quality of Life Questionnaire for Adult Korean Asthmatics (Severity and frequency of symptoms, Activity limitation, Patients' stress and concern about asthma and asthma exacerbation	—

Secondary

Measure	Time frame
Asthma Control Questionnaire (Day symptom, Night symptom, Reliever use, Activity limitation, Forced expiratory volume in 1 second on spirometry);Asthma Control Test (Day symptom, Night symptom, Reliever use, Activity limitation, Overall asthma control);Forced expiratory volume in 1 second in pulmonary function test;Skill in handling inhaler;Compliance to inhaler;Preference of inhaler	—

Countries

Korea, Republic of

Contacts

Public ContactSang Min Lee

Gachon University Gil Medical Center

sangminlee77@naver.com+82-32-460-2634

Outcome results